NCT01339624

Brief Summary

The purpose of this study is to determine whether nasal fentanyl is effective in the treatment of renal colic in adults in emergency department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 20, 2011

Completed
Last Updated

April 20, 2011

Status Verified

September 1, 2009

Enrollment Period

8 months

First QC Date

April 15, 2011

Last Update Submit

April 19, 2011

Conditions

Keywords

analgesiarenal colicketorolacnasal fentanylmorphine.treatment of acute renal colic

Outcome Measures

Primary Outcomes (1)

  • Change in visual analogue scale pain intensity score

    This measure was obtained using a 10-cm with marked numbers visual analog scale (VAS score).

    30 and 60 minutes

Secondary Outcomes (2)

  • Use of rescue therapy at 30 minutes

    30 MINUTES

  • The occurrence of adverse events

    60 minutes

Study Arms (2)

NASAL FENTANYL,

ACTIVE COMPARATOR
Drug: FENTANYL

KETOROLAC + MORPHINE

ACTIVE COMPARATOR
Drug: Ketorolac Tromethamine AND morphine

Interventions

FENTANYL CITRATE, NASAL, 3 GAMMA/KG

NASAL FENTANYL,

morphine 5 MG diluted in saline solution 100 ml followed by 2-ml ampoule of ketorolac 30 MG in saline solution 100 ml was infused:

KETOROLAC + MORPHINE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patients were adults aged 18 to 65 years, presenting in ED with classical clinical symptoms of renal colic (sudden monolateral flank pain with inguinal irradiation) with a 10-cm visual analog scale (VAS) greater than or equal to 7

You may not qualify if:

  • Were analgesia within 6 hours of arrival
  • Allergy to opiates and NSAIDs
  • Opiates abuse, known or suspected abdominal aortic dissection or aneurism,
  • Presence of peritonitis
  • Hemodynamic instability
  • Pregnancy, breastfeeding, anticoagulant therapy.
  • Patients with known renal, pulmonary, cardiac or hepatic failure, as well as those with renal transplantation, were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Valduce Hospital

Como, 22100, Italy

Location

MeSH Terms

Conditions

Renal ColicAgnosia

Interventions

FentanylKetorolac TromethamineMorphine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsIndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 15, 2011

First Posted

April 20, 2011

Study Start

January 1, 2009

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

April 20, 2011

Record last verified: 2009-09

Locations